Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Jan 24:2018:6597387.
doi: 10.1155/2018/6597387. eCollection 2018.

Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome

Beata Morawiec  1 , Damian Kawecki  1 , Brygida Przywara-Chowaniec  1 , Mariusz Opara  1 , Piotr Muzyk  1 , Lam Ho  2 , Lui Chun Tat  3 , Artur Gabrysiak  1 , Olivier Muller  4 , Ewa Nowalany-Kozielska  1
Affiliations
Clinical Trial

Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome

Beata Morawiec et al. Dis Markers. .

Abstract

Background: In patients admitted with chest pain and suspected acute coronary syndrome (ACS), it is crucial to early identify those who are at higher risk of adverse events. The study aim was to assess the predictive value of copeptin in patients admitted to the emergency department with chest pain and nonconclusive ECG.

Methods: Consecutive patients suspected for an ACS were enrolled prospectively. Copeptin and high-sensitive troponin T (hs-TnT) were measured at admission. Patients were followed up at six and 12 months for the occurrence of death and major adverse cardiac and cerebrovascular events (MACCE).

Results: Among 154 patients, 11 patients died and 26 experienced MACCE. Mortality was higher in copeptin-positive than copeptin-negative patients with no difference in the rate of MACCE. Copeptin reached the AUC 0.86 (0.75-0.97) for prognosis of mortality at six and 0.77 (0.65-0.88) at 12 months. It was higher than for hs-TnT and their combination at both time points. Copeptin was a strong predictor of mortality in the Cox analysis (HR14.1 at six and HR4.3 at 12 months).

Conclusions: Copeptin appears to be an independent predictor of long-term mortality in a selected population of patients suspected for an ACS. The study registration number is ISRCTN14112941.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival curves or copeptin (a) and hs-TnT (b). Hs-TnT: high-sensitive troponin T.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Roffi M., Patrono C., Collet J. P., et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) European Heart Journal. 2016;37(3):267–315. doi: 10.1093/eurheartj/ehv320. - DOI - PubMed
    1. Thygesen K., Alpert J. S., White H. D., Joint ESCAAHAWHFTFftRoMI Universal definition of myocardial infarction. European Heart Journal. 2007;28(20):2525–2538. doi: 10.1093/eurheartj/ehm355. - DOI - PubMed
    1. O'Donoghue M. L., Morrow D. A., Cannon C. P., et al. Multimarker risk stratification in patients with acute myocardial infarction. Journal of the American Heart Association. 2016;5(5, article e002586) doi: 10.1161/JAHA.115.002586. - DOI - PMC - PubMed
    1. Morawiec B., Kawecki D. Copeptin: a new marker in cardiology. Journal of Cardiovascular Medicine. 2013;14(1):19–25. doi: 10.2459/JCM.0b013e3283590d59. - DOI - PubMed
    1. Lui C. T., Lam H., Cheung K. H., et al. Role of copeptin in dual-cardiac marker strategy for patients with chest pain presented to ED. The American Journal of Emergency Medicine. 2015;33(12):1732–1736. doi: 10.1016/j.ajem.2015.08.011. - DOI - PubMed

LinkOut - more resources